BACKGROUND: Metastasis to choroid is the most common intraocular malignancy, arising most frequently from carcinoma of breast in women and lung in men. Recent case reports have described successful use of intravitreal bevacizumab to achieve local control of such tumours. MATERIALS AND METHODS: Five cases of choroidal metastases from varying primaries: breast, lung, and colon were treated with intravitreal bevacizumab, and tumour response observed and documented with serial photographs and B-scans. RESULTS: Four of the five tumours were seen to progress despite intravitreal bevacizumab treatment. CONCLUSIONS: Intravitreal bevacizumab as the primary treatment of choroidal metastases is not recommended and should not delay more effective alternative treatments.
BACKGROUND: Metastasis to choroid is the most common intraocular malignancy, arising most frequently from carcinoma of breast in women and lung in men. Recent case reports have described successful use of intravitreal bevacizumab to achieve local control of such tumours. MATERIALS AND METHODS: Five cases of choroidal metastases from varying primaries: breast, lung, and colon were treated with intravitreal bevacizumab, and tumour response observed and documented with serial photographs and B-scans. RESULTS: Four of the five tumours were seen to progress despite intravitreal bevacizumab treatment. CONCLUSIONS: Intravitreal bevacizumab as the primary treatment of choroidal metastases is not recommended and should not delay more effective alternative treatments.
Authors: L Amselem; E Cervera; M Díaz-Llopis; J Montero; M Garcia-Pous; P Udaondo; S García-Delpech; D Salom Journal: Eye (Lond) Date: 2006-11-24 Impact factor: 3.775
Authors: Joanna Wisniewska-Kruk; Ingeborg Klaassen; Ilse M C Vogels; Aaron L Magno; Chooi-May Lai; Cornelis J F Van Noorden; Reinier O Schlingemann; Elizabeth P Rakoczy Journal: Exp Eye Res Date: 2014-04-03 Impact factor: 3.467
Authors: Sebastian P Haen; Philipp Stroebel; Alexander Marx; Daniela Suesskind; Falko Fend; Ursula Reichmann; Hans-Georg Kopp; Lothar Kanz; Frank Mayer Journal: BMC Cancer Date: 2015-12-16 Impact factor: 4.430